SCHEDULE: AQR Capital Management Discloses 5.1% Stake in Phreesia

AQR Capital Management, through its subsidiaries, has reported beneficial ownership of 5.1% of Phreesia, Inc.'s common stock as of June 30, 2026.

Summary

• AQR Capital Management, LLC and AQR Capital Management Holdings, LLC have filed a Schedule 13G, indicating their beneficial ownership of Phreesia, Inc. common stock.
• The filing, dated August 12, 2026, reports that as of June 30, 2026, AQR Capital Management beneficially owned 3,151,453 shares of Phreesia's common stock.
• This represents 5.1% of the class of securities.
• AQR Capital Management, LLC is a wholly owned subsidiary of AQR Capital Management Holdings, LLC.
• The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this filing as neutral to slightly positive, indicating a significant but not overwhelming stake in the company by a major investment manager. The disclosure itself is routine for institutional investors.

Positives

• A significant institutional investor, AQR Capital Management, has taken a notable stake (5.1%) in Phreesia, Inc., which can be seen as a vote of confidence.
• The filing is a standard disclosure, indicating compliance with regulatory requirements.

Negatives

• The filing does not contain any negative information regarding the company's performance or operations; it is purely a disclosure of ownership.

Risks

• While not explicitly stated as a risk in this filing, any significant shift in ownership by a large institutional investor could potentially impact stock price volatility.
• The filing does not detail the specific investment strategy or rationale behind acquiring the stake, leaving potential future actions by AQR Capital Management open to interpretation.

Future Outlook

This filing is a disclosure of ownership and does not contain forward-looking statements or guidance from Phreesia, Inc. management.

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11."

Industry Context

StockSavvy.ai notes that the acquisition of a significant stake by an institutional investor like AQR Capital Management is a common occurrence in the healthcare technology sector, reflecting active portfolio management and strategic positioning by investment firms.

Comparison to Industry Standards

• Institutional ownership stakes in publicly traded companies typically range from single digits to substantial majorities. A 5.1% stake is a common threshold for significant institutional investor reporting.
• Many investment management firms, such as BlackRock, Vanguard, and State Street, hold similar or larger stakes in comparable healthcare technology companies, making AQR's position within industry norms.

Stakeholder Impact

• Shareholders: The disclosure may influence investor sentiment, potentially impacting share price due to the increased institutional interest.
• Management and Board: The presence of a significant institutional holder like AQR may lead to increased scrutiny and engagement on corporate strategy and governance.

Next Steps

• AQR Capital Management will continue to hold or potentially adjust its stake in Phreesia, Inc. in accordance with its investment strategies.
• Phreesia, Inc. will continue its business operations as disclosed in its other SEC filings.

Key Dates

Keywords

Phreesia, AQR Capital Management, Schedule 13G, Beneficial Ownership, Institutional Investor, Common Stock, Investment Management